Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 18:2020:9390878.
doi: 10.1155/2020/9390878. eCollection 2020.

Role of Wnt/ β-Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer

Shengli Yuan  1 , Fengying Tao  1 , Xinglin Zhang  1 , Yan Zhang  1 , Xingxing Sun  2 , Dapeng Wu  1
Affiliations
Review

Role of Wnt/ β-Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer

Shengli Yuan et al. Biomed Res Int. .

Abstract

Colorectal cancer (CRC) is a common malignancy with high morbidity and mortality worldwide. To date, chemotherapy plays an important role in the treatment of CRC patients. Multidrug resistance (MDR) is one of the major hurdles in chemotherapy for CRC, and the underlying mechanisms need to be explored. Studies have demonstrated that Wnt/β-catenin signaling plays a critical role in oncogenesis and tumor development, and its function in inhibiting apoptosis could facilitate tumor chemoresistance. Recent investigations have also suggested the regulatory effects of the Wnt/β-catenin signaling pathway in response to chemotherapeutic agents in CRC. Here, we particularly focus on reviewing the evidences suggesting the mechanisms of Wnt/β-catenin signaling in the chemoresistance modulation of colorectal cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interests on the manuscript.

Figures

Figure 1
Figure 1
Role of the Wnt/β-catenin signaling pathway in chemoresistance of colorectal cancer.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bray F., Ferlay J., Soerjomataram I., Siegel R. L., Torre L. A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians. 2018;68(6):394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Wang Y. J., Zhang Y. K., Zhang G. N., et al. Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: in vitro and in vivo study. Cancer Letters. 2017;396:145–154. doi: 10.1016/j.canlet.2017.03.011. - DOI - PMC - PubMed
    1. Sartore-Bianchi A., Loupakis F., Argilés G., Prager G. W. Challenging chemoresistant metastatic colorectal cancer: therapeutic strategies from the clinic and from the laboratory. Annals of Oncology. 2016;27(8):1456–1466. doi: 10.1093/annonc/mdw191. - DOI - PubMed
    1. Kunjachan S., Rychlik B., Storm G., Kiessling F., Lammers T. Multidrug resistance: physiological principles and nanomedical solutions. Advanced Drug Delivery Reviews. 2013;65(13-14):1852–1865. doi: 10.1016/j.addr.2013.09.018. - DOI - PMC - PubMed
    1. Bloise E., Ortiga-Carvalho T. M., Reis F. M., Lye S. J., Gibb W., Matthews S. G. ATP-binding cassette transporters in reproduction: a new frontier. Human Reproduction Update. 2016;22(2):164–181. doi: 10.1093/humupd/dmv049. - DOI - PMC - PubMed

MeSH terms